Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts

In the latest trading session, Boston Scientific (BSX) closed at $95.85, marking a -1.82% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.34%. Meanwhile, the Dow experienced a rise of 0.09%, and the technology-dominated Nasdaq saw an increase of 0.42%. Heading into today, shares of the medical device manufacturer had lost 8.47% over the past month, lagging the Medical sector's gain of 1.97% and the S&P 500's gain of 3.54%.The upcoming earnings release of Boston Scientific will be of great interest to investors. The company's earnings report is expected on October 22, 2025. It is anticipated that the company will report an EPS of $0.71, marking a 12.7% rise compared to the same quarter of the previous year. Alongside, our most recent consensus estimate is anticipating revenue of $4.95 billion, indicating a 17.69% upward movement from the same quarter last year. For the full year, the Zacks Consensus Estimates are projecting earnings of $2.98 per share and revenue of $19.84 billion, which would represent changes of +18.73% and +18.46%, respectively, from the prior year. It's also important for investors to be aware of any recent modifications to analyst estimates for Boston Scientific. Recent revisions tend to reflect the latest near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits. Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system. The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.01% decrease. Boston Scientific presently features a Zacks Rank of #3 (Hold). In terms of valuation, Boston Scientific is currently trading at a Forward P/E ratio of 32.81. For comparison, its industry has an average Forward P/E of 18.43, which means Boston Scientific is trading at a premium to the group. One should further note that BSX currently holds a PEG ratio of 2.35. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Medical - Products was holding an average PEG ratio of 2.27 at yesterday's closing price. The Medical - Products industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 81, finds itself in the top 33% echelons of all 250+ industries. The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions. Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.See "2nd Wave" AI stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Boston Scientific Corporation (BSX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks